Tag - TLT

Developments

Theralase researcher discovers potent anti-cancer drugs

Theralase Technologies (OTCQX:TLTFF; TSXV:TLT) recently identified a new platform of super potent anti-cancer drugs, or PDCs, discovered by Dr. Sherri McFarland, Professor, Department of Chemistry and Biochemistry...

November 14, 2017

Markets

Echelon starts Theralase at speculative buy

Echelon Wealth Partners initiated coverage of Theralase Technologies (TSXV:TLT) with a “speculative buy” rating and one-year price target of 90 cents. The stock closed at 47 cents on Sept. 1. Analyst Doug Loe writes...

September 5, 2017

Tag - TLT

Theralase researcher discovers potent anti-cancer drugs

Echelon starts Theralase at speculative buy

General

More